Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Miist Therapeutics is revolutionizing acute care with inhaled therapies that provide rapid relief within seconds. Our proprietary inhaler delivers ultra-fine particles to the lung periphery, ensuring swift absorption into the bloodstream. Our lead program, MST01, is a smoking cessation treatment that eliminates 93% of cravings within two minutes and gradually reduces nicotine dosage over 12 weeks. Additionally, MST02, currentl...
    Miist Therapeutics is revolutionizing acute care with inhaled therapies that provide rapid relief within seconds. Our proprietary inhaler delivers ultra-fine particles to the lung periphery, ensuring swift absorption into the bloodstream. Our lead program, MST01, is a smoking cessation treatment that eliminates 93% of cravings within two minutes and gradually reduces nicotine dosage over 12 weeks. Additionally, MST02, currently in preclinical development, aims to offer migraine sufferers peak relief within five minutes. Our mission is to set a new standard in acute care by developing fast-acting treatments across various therapeutic areas.

    List your booth number for exhibitions, ask us